ÂÜÀòÂÒÂ×

Alan Rudolph is an accomplished leader in the fields of bioscience, technology, and research management, currently serving as the Interim Chief Technology Officer at Innosphere Ventures since January 2024 and the Interim Chief Executive Officer at PhotonPharma since April 2018. With extensive experience on multiple boards, including the Colorado BioScience Association and the International Neuroscience Network Foundation, Alan has played a significant role in advancing cancer therapeutics and promoting diversity in science. Previous positions include Vice President of Research at Colorado State University, Director of Biological and Chemical Defense at the U.S. Department of Homeland Security, and Director of the Chemical and Biological Defense program at the Pentagon. Alan founded Cellphire Inc. and holds an MBA from The George Washington University, a PhD in Zoology from the University of California, Davis, and a BS from the University of Michigan.